Results 161 to 170 of about 46,287 (264)
Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort
, 2020 Christophe Rosty, Mark Clendenning, Michael D. Walsh, Stine V. Eriksen, Melissa C. Southey, Ingrid Winship, Finlay Macrae, Alex Boussioutas, Nicola Poplawski, Susan Parry, Julie Arnold, Joanne Young, Graham Casey, Robert W. Haile, Steven Gallinger, Loı̈c Le Marchand, Polly A. Newcomb, John D. Potter, Melissa Derycke, Noralane M. Lindor, Stephen N. Thibodeau, John A. Baron, Aung Ko Win, John L. Hopper, Mark A. Jenkins, Daniel D. Buchanan +25 moreopenalex +1 more sourceEvidence for classification of c.1852_1853AA>GC in MLH1 as a neutral variant for Lynch syndrome [PDF]
, 2011 Adela Castillejo, Carla Guarinós, Ana Martínez-Cantó, Víctor Manuel Barberá, Cecilia Egoavil, M.I. Castillejo, Lucía Pérez–Carbonell, Ana‐Beatriz Sánchez‐Heras, Ángel Segura, Enrique Ochoa, Rafael Lázaro, Clara Ruíz-Ponte, Luís Bujanda, Montserrat Andreu, Antoni Castells, Ãngel Carracedo, Xavier Llor, Juan Clofent, Cristina Alenda, Artemio Payá, Rodrigo Jover, José Luís Soto +21 moreopenalex +1 more sourceGermline MLH1 c.-42 C > T is a likely pathogenic variant predisposing to a reduced-penetrance/modified Lynch syndrome phenotype featuring MLH1-methylated cancers. [PDF]
Fam CancerBuchanan DD, Alvarez R, Mahmood K, Clendenning M, Georgeson P, Walker R, Como J, Preston SG, Joseland S, Mohammadsaeedi K, Aguirre F, Zhou L, Hazelett DJ, Jenkins MA, Rosty C, Winship IM, Macrae FA, Dwarte TM, Nixon D, Hitchins MP, Joo JE. +20 moreeuropepmc +1 more sourceDNA Polymerases as Potential Therapeutic Targets for Cancers Deficient in the DNA Mismatch Repair Proteins MSH2 or MLH1 [PDF]
, 2010 Sarah A. Martin, Nuala McCabe, Michelle J Mullarkey, Robert Cummins, Darren J. Burgess, Yusaku Nakabeppu, Sugako Oka, Elaine W. Kay, Christopher J. Lord, Alan Ashworth +9 moreopenalex +1 more source